Inhibition of cytokine-induced prostanoid biogenesis by phytochemicals in human colonic fibroblasts

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1762, Issue 1, 2006, Pages 124-130

  Russell, Wendy R ^a   Drew, Janice E ^a   Scobbie, Lorraine ^a   Duthie, Garry G ^a  

^a ROWETT RESEARCH INSTITUTE   (United Kingdom)

Author keywords

Colon cancer; Cyclooxygenase; IL 1 ; Inflamation; Phenylpropanoid; Prostaglandin H synthase

Indexed keywords

BENZOIC ACID; CARBON; CYTOKINE; PLANT MEDICINAL PRODUCT; PROSTAGLANDIN SYNTHASE; PROSTANOID;

ARTICLE; BIOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; FIBROBLAST; HUMAN; HUMAN CELL; HYDROXYLATION; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; SCREENING; STRUCTURE ANALYSIS; UPREGULATION;

CELLS, CULTURED; COLON; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLASTS; HUMANS; PLANT COMPONENTS; PROSTAGLANDINS; UP-REGULATION;

EID: 29744447309     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2005.08.007     Document Type: Article

References (24)

1. D.M. Parkin, F. Bray, J. Ferlay, and P. Pisani Estimating the world cancer burden: Globocan 2000 Int. J. Cancer 94/2 2001 153 156
2. E. Pikarsky, R.M. Porat, I. Stein, R. Abramovitch, S. Amit, S. Kasem, E. Gutkovich-Pyest, S. Urieli-Shoval, E. Galun, and Y. Ben-Neriah NF-kB functions as a tumour promoter in inflammation-associated cancer Nature 431 2004 461 466
3. 2 in colonic mucosa of patients with Crohn's disease and ulcerative colitis Gut 35 1994 1593 1598
4. C.E. Eberhart, R.J. Coffey, A. Radhika, F.M. Giardiello, and R.N. Dubois Up-regulation of cyclooxygenase gene expression in human colorectal adenomas and adenocarcinomas Gastroenterology 107 1994 1183 1188
5. E. Giovanucci, E.B. Rimm, M.J. Stampfer, G.A. Colditz, A. Ascherio, and W.C. Willet Aspirin use and the risk for colorectal cancer and adenoma in male health professionals Ann. Int. Med. 141 1994 241 246
6. J.A. Baron, B.F. Cole, R.S. Sandler, R.W. Haile, D. Ahnen, R. Bresalier, G. McKeown-Eyssen, R.W. Summers, R. Rothstein, C.A. Burke, D.C. Snover, T.R. Church, J.I. Allen, M. Beach, G.J. Beck, J.H. Bond, T. Byers, E.R. Greenberg, J.S. Mandel, N. Marcon, L.A. Mott, L. Pearson, F. Saibil, and R.U. van Stolk A randomised trial of aspirin to prevent colorectal cancer N. Engl. J. Med. 348/10 2003 891 899
7. P. Juni, L. Nartey, S. Reichenbach, R. Sterchi, P.A. Dieppe, and M. Egger Risk of cardiovascular events and rofecoxib: cumulative meta-analysis Lancet 364/9450 2004 2021 2029
8. E. Riboli, and T. Norat Epidemiologic evidence of the protective effect of fruit and vegetables on cancer risk Am. J. Clin. Nut. 78/3 2003 559S 569S
9. Y.T. Zhu, P. Hua, and P. Lance Cyclooxygenase-2 expression and prostanoid biogenesis reflect clinical phenotype in human colorectal fibroblast strains Cancer Res. 63/2 2003 522 526
10. E.C. Kim, Y. Zhu, V. Anderson, D. Sciaky, H.J. Cao, H. Meekins, T.J. Smith, and P. Lance Cytokine-mediated PGE2 expression in human colon fibroblasts Am. J. Physiol., Cell Physiol. 275/44 1998 C988 C994
11. W.R. Russell, M.J. Burkitt, A.R. Forrester, and A. Chesson Oxidative coupling during lignin polymerization is determined by unpaired electron delocalization within parent phenylpropanoid radicals Arch. Biochem. Biophys. 332/2 1996 357 366
12. W.R. Russell, M. Burkitt, J.L. Scobbie, and A. Chesson Radical formation and coupling of hydroxycinnamic acids containing 1,2-dihydroxy substituents Bioorg. Chem. 31 2003 206 215
13. M.M. Bradford Rapid and sensitive method for quantification of microgram quantities of protein utilizing principle of protein-dye binding Anal. Biochem. 72 1976 248 254
14. J.R. Kiefer, J.L. Pawlitz, K.T. Moreland, R.A. Stegeman, W.F. Hood, J.K. Gierse, A.M. Stevens, D.C. Goodwin, S.W. Rowlinson, L.J. Marnett, W.C. Stallings, and R.G. Kurumbail Structural insights into the stereochemistry of the cyclooxygenase reaction Nature 405/6782 2000 97 101
15. W.A. Van der Donk, A.-L. Tsai, and R.J. Kulmacz The cyclooxygenase reaction mechanism Biochemistry 41/52 2002 15451 15458
16. V. Koshkin, and H.B. Dubford Coupling of the peroxidase and cyclooxygenase reactions of prostaglandin H synthase Biochim. Biophys. Acta 1430 1999 341 348
17. G. Trummlitz, and J. van Ryn Designing selective COX-2 inhibitors: molecular modeling approaches Curr. Opin. Drug Discov. Dev. 5/4 2002 550 561
18. R. Pouplana, J.J. Lozano, C. Perez, and K. Ruiz Structure-based QSAR study on differential inhibition of human prostaglandin endoperoxide H synthase-2 (COX-2) by nonsteroidal anti-inflammatory drugs J. Comput. Aided Mol. Des. 16/10 2002 683 709
19. H.J. Kim, C.H. Chae, K.Y. Yi, K.L. Park, and S.E. Yoo Computational studies of COX-2 inhibitors: 3D-QSAR and docking Bioorg. Med. Chem. 12/7 2004 1629 1641
20. W.R. Russell, L. Scobbie, and A. Chesson Structural modification of phenylpropanoid-derived compounds and the effects on their participation in redox processes Bioorg. Med. Chem. 13/7 2005 2537 2546
21. J. Couzin Drug safety-Withdrawal of Vioxx casts a shadow over COX-2 inhibitors Science 306/5695 2004 384 385
22. D.W.J. Clark, D. Layton, and S.A.W. Shakir Do some inhibitors of COX-2 increase the risk of thromboembolic events? Linking pharmacology with pharmacoepidemiology Drug Safety 27/7 2004 427 456
23. M.B. Sporn, and N. Suh Chemoprevention: an essential approach to controlling cancer Nat. Rev., Cancer 2 2002 537 543
24. K.-S. Chun, and Y.-J. Surh Signal transduction pathways regulating cylooxygenase-2 expression: potential molecular targets for chemoprevention Biochem. Pharmacol. 68 2004 1089 1100